The Nimitz Group is a leader in government relations excellence, recognized as the premier firm dedicated to veteran policy. Founded in 2016 with a dedication to creating significant change, the Nimitz Group has served as a prominent voice in Washington, DC for the well-being and rights of American veterans.

About Us

Learn more

Our Services

  • Engaging with policymakers to champion legislative initiatives that directly veterans’ affairs, ensuring that their needs and concerns are effectively communicated and addressed within the legislative process

  • Offering expert advice and consultation on navigating government structures, fostering relationships with key stakeholders, and providing strategic guidance to achieve favorable policy outcomes for veterans

  • Conducting in-depth analysis and research on political landscapes to identify opportunities and challenges for veterans, providing strategic insights that guide effective advocacy and lobbying efforts

    • Crafting and executing comprehensive communication strategies that resonate with both national audiences and grassroots communities, effectively conveying the importance of veterans’ issues and building public support for favorable policy outcomes

  • Developing comprehensive policy proposals tailored to address the unique needs of veterans and guiding the implementation of these policies through effective advocacy, lobbying, and collaboration with relevant stakeholders

  • Establishing and nurturing strategic relationships with policymakers, government officials, and key influencers to build a strong network that can be leveraged to advance veterans’ interests and create impactful advocacy initiatives

Learn More

Newsletters

Your weekly guide to Veterans Affairs, key health challenges like PTS and TBIs, veteran-specific funding opportunities, military family policy developments, and more.

Subscribe

Tracking the latest developments in AI, cybersecurity, emerging technology trends, and pivotal tech-related hearings shaping policy and industry.

Subscribe

Navigating the intersections of pharmaceuticals, federal health policy developments, evolving regulatory frameworks, and influential health hearings in Congress.

Subscribe

Contact Us